期刊文献+

CD133^+人脐血造血祖细胞的干性维持培养及鉴定

Long-term culture and identification of CD133^+ hematopoietic progenitor cells from human umbilical cord blood
下载PDF
导出
摘要 目的从人脐带血中分选出CD133+造血祖细胞,并进行长时间干性维持培养。方法通过免疫磁珠法分选出人脐带血中的CD133+造血祖细胞,经流式细胞仪检测免疫磁珠分选后的CD133+造血祖细胞。采用五种方法扩增培养该细胞,8周后,再通过细胞形态学、流式细胞术、免疫细胞化学和免疫荧光对细胞进行干性鉴定,探索最佳干性维持培养方法。结果通过免疫磁珠法可以从人脐带血中分选出80%以上的CD133+造血祖细胞。采用优化的无血清培养基培养8周之后,CD133+造血祖细胞可得到有效扩增。而其他的培养基会使CD133+造血祖细胞由半悬浮细胞分化为梭形贴壁细胞,并且细胞状态欠佳。结论利用免疫磁珠法分选出的CD133+造血祖细胞,采用优化的无血清培养基能够有效扩增该细胞,并可长期有效的维持其干性。 Objective To isolate CD133+ hematopoietic progenitor cells from human umbilical cord blood and optimize the culture condition for maintaining their stem cell characteristics.Methods CD133+ hematopoietic progenitor cells were isolated from human umbilical cord blood using magnetic cell sorting system,and the cells were detected by flow cytometry.Four methods were used for culturing cells.After 8 weeks' culture,cytomorphology,flow cytometry,immunocytochemistry and immunofluorescence assay were used to identify the characteristics of the stem cells.Results Over 80% of CD133+ hematopoietic progenitor cells were isolated from human umbilical cord blood using magnetic cell sorting system.The cells were effectively expanded using optimized serum-free medium after 8 weeks of cell culture,whereas the cells in other media differentiated into adherent cells in a poor state.Conclusion The optimized serum-free medium allows effective expansion of CD133+ hematopoietic progenitor cells that maintain stem cell characteristics after a long-term culture.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第3期349-353,共5页 Journal of Southern Medical University
基金 国家自然科学基金(30871156) 广东省科技计划项目(2009B030803041 2010B031600091) 广东省自然科学基金(8151051501000057)~~
关键词 人脐血 CD133+ 造血祖细胞 干性 培养 鉴定 human umbilical cord blood CD133+ hematopoietic progenitor cells stem cell characteristics culture identification
  • 相关文献

参考文献17

  • 1Kekarainen T,Mannelin S,Laine J,et al.Optimization ofimmunomagnetic separation for cord blood-derived hematopoieticstem cell[s J].BMC Cell Biol,2006,7(30):30.
  • 2Fernandes R,Kusel M,Cyr M,et al.Cord blood hemopoieticprogenitor profiles predict acute respiratory symptoms in infancy[J].PediatrAllergy Immunol,2008,19(3):239-47.
  • 3Giorgetti A,Montserrat N,Rodriguez-Piza I,et al.Generation ofinduced pluripotent stem cells from human cord blood cells withonly two factors:Oct4 and Sox2[J].Nat Protoc,2010,5(4):811-20.
  • 4Elkhafif N,El Baz H,Hammam O,et al.CD133(+)humanumbilical cord blood stem cells enhance angiogenesis in experi-mental chronic hepatic fibrosi[s J].APMIS,2011,119(1):66-75.
  • 5Jensen GS,Hart AN,Zaske LA,et al.Mobilization of humanCD34+CD133+and CD34+CD133(-)stem cells in vivo byconsumption of an extract from Aphanizomenon flos-aquae--relatedto modulation of CXCR4 expression by an L-selectin ligand[J] Cardiovasc Revasc Med,2007,8(3):189-202.
  • 6Pafumi C,Bosco P,Cavallaro A,et al.Two CD34+stem cells fromumbilical cord blood enrichment methods[J].Pediatr HematolOncol,2002,19(4):239-45.
  • 7Buhring HJ,Seiffert M,Bock TA,et al.Expression of novel surfaceantigens on early hematopoietic cells[J].Ann N Y Acad Sci,1999,872(6):25-39.
  • 8Kishimoto S,Nakamura S,Nakamura S,et al.Cytokine-immobilized microparticle-coated plates for culturing hemato-poietic progenitor cell[s J].J Control Release,2009,133(3):185-90.
  • 9Kirshenbaum AS,Akin C,Goff JP,et al.Thrombopoietin alone or inthe presence of stem cell factor supports the growth of KIT(CD117)low/MPL(CD110)+human mast cells from hematopoieticprogenitor cell[s J].Exp Hematol,2005,33(4):413-21.
  • 10Wodnar-Filipowicz A,Lyman SD,Gratwohl A,et al.Flt3ligandlevel reflects hematopoietic progenitor cell function in aplasticanemia and chemotherapy-induced bone marrow aplasia[J].Blood,1996,88(12):4493-9.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部